Analytica announced the receipt of 510(k) clearance from the US Food and Drug Administration to market the AutoStart Burette in the United States. [More]

Sigma Pharmaceuticals requested its shares be suspended from trading as the company expects to make an announcement to the market in relation to revised earnings guidance for the year ended 31 January 2010. [More]

Healthscope shares were placed in trading pending an announcement regarding the outcome of late stage negotiations regarding a potential acquisition, and an associated capital raising. [More]

Pharmaxis said it had completed the first Phase I clinical trial, which was designed to determine the tolerance and pharmacokinetic profile of PXS25, following intravenous administration in healthy volunteers. [More]

Biota Holdings said it had received written notification from GlaxoSmithKline that Relenza sales were $462m and indicative royalties were $32.6m, for the December 2009 quarter. [More]

Medic Vision said it has successfully completed the acquisition of the digital marketing and communications company, cBox. [More]

CathRx said sales for the second quarter of FY10 missed forecasts at $151,308. [More]

Pharmaxis today announced the results of the phase III trial of Bronchitol for the treatment of cystic fibrosis. [More]

Sonic Healthcare said it had acquired Rhode Island based East Side Clinical Laboratory for an undisclosed sum. [More]

Starpharma Holdings said that it had raised $15.6m through a private placement to various investors, including the lead investor Orbis. [More]